Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children

Part of paid clinical trials in Aurora, Colorado.

Sponsor
University of Colorado, Denver
Study ID
NCT04993859
Status
Recruiting

Conditions

  • Bladder Dysfunction
  • Survivors of Childhood Cancer

Eligibility Criteria

Sex
ALL
Age
5 Years - 13 Years
Healthy Volunteers
Not accepted

Interventions

  • Non-invasive Urodynamic Test (niUDS) — DIAGNOSTIC_TEST
    A noninvasive urodynamics is a simple test used to evaluate urinary flow.
  • Urinary proteomic screen — DIAGNOSTIC_TEST
    Urine proteomics is a powerful platform to identify urinary excreted proteins and peptides in different stages of disease or therapy and to determine their quantity, functions, and interaction.
  • Dysfunctional Voiding Symptom Score Survey (DVSS) — OTHER
    The Dysfunctional Voiding Symptom Score provides accurate and objective grading of voiding behaviors of children.

Study Details

The over-arching aim of this study is to evaluate the effects of two specific anti-cancer chemotherapies, vincristine and doxorubicin, on bladder function and urine composition.

Key Dates

Start date
Jun 2, 2021
Status verified
Oct 2025
Primary completion
Jul 9, 2026
Completion
Jul 9, 2026

Study Design

Enrollment
152 participants (estimated)

Arms

  • Arm: Male Cancer Survivors with DVSS Score ≥ 9
    Childhood cancer survivors treated with DOX and/or VCR with evidence of BD on DVSS
  • Arm: Female Cancer Survivors with DVSS Score ≥ 6
    Childhood cancer survivors treated with DOX and/or VCR with evidence of BD on DVSS
  • Arm: Male Cancer Survivors with DVSS Score < 9
    Childhood cancer survivors treated with DOX and/or VCR without evidence of BD on DVSS
  • Arm: Female Cancer Survivors with DVSS Score < 6
    Childhood cancer survivors treated with DOX and/or VCR without evidence of BD on DVSS

Primary Outcome Measure

Proportion of non-normal niUDS patterns between groups [ Time Frame: Immediately after niUDS done at the first visit ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Children's Hospital ColoradoAuroraColorado80045
Gemma Beltran
(720) 777-4418
Nicholas Cost, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Aurora, CO

Related Studies